Manu Ohri serves as Executive at GT Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Manu Ohri has executed 8 insider transactions totaling $25.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 14, 2024 involved receiving (via award) 5,000 shares valued at $0.
Manu Ohri currently holds 5,001 shares of GT Biopharma, Inc. (GTBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Manu Ohri has been a net buyer of GTBP stock. They have purchased $25.0K and sold $0 worth of shares.
Manu Ohri's most recent insider trade was on Feb 14, 2024, when they sold 5,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.29 |
| Discretionary |
| Aug 11, 2023 | GTBP | $58.0K | Other | 200,000 | $0.29 | Discretionary |
| Aug 11, 2023 | GTBP | $58.0K | Other | 200,000 | $0.29 | Discretionary |
| Apr 6, 2023 | GTBP | $25.0K | Purchase | 50,000 | $0.50 | Discretionary |
| Jul 15, 2022 | GTBP | $0 | Other | 100,000 | $N/A | Discretionary |
| Jul 15, 2022 | GTBP | $0 | Other | 100,000 | $N/A | Discretionary |
| Jul 15, 2022 | GTBP | $0 | Award | 100,000 | $N/A | Discretionary |